145 related articles for article (PubMed ID: 1973398)
1. [Pharmacological studies of celiprolol: I. Beta-blocking effect, intrinsic sympathomimetic activity, vasodilating and hypotensive effects].
Miura A; Kimura Y; Inoue K; Matsuzaki T; Ochi S; Hamada K; Hayashi S; Tamura M; Kano S; Kimura K
Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):191-200. PubMed ID: 1973398
[TBL] [Abstract][Full Text] [Related]
2. Partial agonist activity of celiprolol, a cardioselective beta-antagonist.
Ochi S; Nakazawa M; Kimura T; Nakagawa Y; Imai S
Eur J Pharmacol; 1991 Feb; 194(1):1-5. PubMed ID: 1676370
[TBL] [Abstract][Full Text] [Related]
3. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
Pittner H
Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
[TBL] [Abstract][Full Text] [Related]
4. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
5. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of celiprolol.
Louis WJ; Drummer OH; Tung LH
Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1281-5. PubMed ID: 1672604
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
Chiu CC; Lin YT; Tsai CH; Liang JC; Chiang LC; Wu JR; Chen IJ; Yeh JL
Gen Pharmacol; 2000 Jun; 34(6):391-400. PubMed ID: 11483288
[TBL] [Abstract][Full Text] [Related]
10. Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity.
Thulesius O; Gjöres JE; Berlin E
Br J Clin Pharmacol; 1982; 13(Suppl 2):229S-230S. PubMed ID: 6125174
[TBL] [Abstract][Full Text] [Related]
11. The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.
Smith RD; Cobuzzi A; Wolf PS; Pruss TP
Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):147-61. PubMed ID: 2870551
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological studies of celiprolol: II. Alpha 2-Adrenoceptor blocking effects of a cardioselective beta-blocker, celiprolol].
Miura A; Ukai Y; Matsuzaki T; Ishima T; Hayashi S; Kano S; Kimura K
Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):201-8. PubMed ID: 1973399
[TBL] [Abstract][Full Text] [Related]
13. Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.
Nganele DM; DeLeonardis VM; Hintze TH
Br J Pharmacol; 1988 Mar; 93(3):501-8. PubMed ID: 2897217
[TBL] [Abstract][Full Text] [Related]
14. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
Jolly SR; Smith RD; Wolf PS; Russ TP
Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
[TBL] [Abstract][Full Text] [Related]
17. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
Tesfamariam B; Allen GT
Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
[TBL] [Abstract][Full Text] [Related]
18. Isoeugenolol: a selective beta1-adrenergic antagonist with tracheal and vascular smooth muscle relaxant properties.
Lin YT; Wu BN; Horng CF; Huang YC; Hong SJ; Lo YC; Cheng CJ; Chen IJ
Jpn J Pharmacol; 1999 Jun; 80(2):127-36. PubMed ID: 10440531
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties.
Sponer G; Bartsch W; Strein K; Müller-Beckmann B; Böhm E
J Cardiovasc Pharmacol; 1987 Mar; 9(3):317-27. PubMed ID: 2437399
[TBL] [Abstract][Full Text] [Related]
20. Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities.
Huang YC; Wu BN; Lin YT; Chen SJ; Chiu CC; Cheng CJ; Chen IJ
J Cardiovasc Pharmacol; 1999 Jul; 34(1):10-20. PubMed ID: 10413061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]